Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$209.01 - $232.56 $15,257 - $16,976
-73 Reduced 0.68%
10,641 $2.32 Million
Q4 2023

Feb 09, 2024

BUY
$197.69 - $227.29 $26,292 - $30,229
133 Added 1.26%
10,714 $2.44 Million
Q3 2023

Nov 20, 2023

SELL
$201.05 - $221.7 $52,876 - $58,307
-263 Reduced 2.43%
10,581 $2.13 Million
Q2 2023

Jul 27, 2023

SELL
$211.93 - $241.33 $83,288 - $94,842
-393 Reduced 3.5%
10,844 $2.62 Million
Q1 2023

May 02, 2023

BUY
$213.32 - $257.83 $435,172 - $525,973
2,040 Added 22.18%
11,237 $2.58 Million
Q4 2022

Feb 01, 2023

SELL
$203.72 - $248.97 $422,107 - $515,865
-2,072 Reduced 18.39%
9,197 $2.16 Million
Q3 2022

Nov 02, 2022

BUY
$204.81 - $262.19 $37,685 - $48,242
184 Added 1.66%
11,269 $2.31 Million
Q2 2022

Jul 25, 2022

SELL
$213.86 - $277.87 $1.54 Million - $2.01 Million
-7,221 Reduced 39.45%
11,085 $2.6 Million
Q1 2022

May 03, 2022

BUY
$259.82 - $298.18 $139,523 - $160,122
537 Added 3.02%
18,306 $4.83 Million
Q4 2021

Jan 25, 2022

SELL
$271.6 - $314.21 $300,661 - $347,830
-1,107 Reduced 5.86%
17,769 $5.58 Million
Q3 2021

Oct 18, 2021

SELL
$274.82 - $308.34 $104,981 - $117,785
-382 Reduced 1.98%
18,876 $5.31 Million
Q2 2021

Jul 12, 2021

BUY
$251.87 - $278.14 $159,433 - $176,062
633 Added 3.4%
19,258 $5.31 Million
Q1 2021

Apr 12, 2021

BUY
$204.88 - $255.03 $276,997 - $344,800
1,352 Added 7.83%
18,625 $4.75 Million
Q4 2020

Jan 11, 2021

BUY
$186.91 - $214.42 $32,335 - $37,094
173 Added 1.01%
17,273 $3.52 Million
Q3 2020

Nov 13, 2020

BUY
$167.03 - $201.3 $2.86 Million - $3.44 Million
17,100 New
17,100 $3.42 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Hohimer Wealth Management, LLC Portfolio

Follow Hohimer Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hohimer Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hohimer Wealth Management, LLC with notifications on news.